Cargando…

A novel prognostic model for papillary thyroid cancer based on epithelial–mesenchymal transition‐related genes

BACKGROUND: The frequent incidence of postsurgical recurrence issues in papillary thyroid cancer (PTC) patients is a primary concern considering the low cancer‐related mortality. Previous studies have demonstrated that epithelial–mesenchymal transition (EMT) activation is closely related to PTC prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Rui, Cao, Zhen, Pan, Meng, Wu, Mengwei, Li, Xiaobin, Yuan, Hongwei, Liu, Ziwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741981/ https://www.ncbi.nlm.nih.gov/pubmed/35608185 http://dx.doi.org/10.1002/cam4.4836

Ejemplares similares

Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma
por: Wu, Mengwei, et al.
Publicado: (2019)

Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma
por: Liu, Rui, et al.
Publicado: (2023)

Progression Risk Assessment of Post-surgical Papillary Thyroid Carcinoma Based on Circular RNA-Associated Competing Endogenous RNA Mechanisms
por: Wu, Mengwei, et al.
Publicado: (2021)

Serum Linkage-Specific Sialylation Changes Are Potential Biomarkers for Monitoring and Predicting the Recurrence of Papillary Thyroid Cancer Following Thyroidectomy
por: Cao, Zhen, et al.
Publicado: (2022)

Nomograms Based on Serum N-glycome for Diagnosis of Papillary Thyroid Microcarcinoma and Prediction of Lymph Node Metastasis
por: Zhang, Zejian, et al.
Publicado: (2022)

Comprehensive analysis of tissue proteomics in patients with papillary thyroid microcarcinoma uncovers the underlying mechanism of lymph node metastasis and its significant sex disparities
por: Cao, Zhen, et al.
Publicado: (2022)

Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma
por: Wu, Mengwei, et al.
Publicado: (2020)

Risk factors for thyroid hormone replacement therapy after hemithyroidectomy and development of a predictive nomogram
por: Cao, Zhen, et al.
Publicado: (2022)

Oral Contraceptive Steroids Promote Papillary Thyroid Cancer Metastasis by Targeting Angiogenesis and Epithelial-Mesenchymal Transition
por: Dehghan, Mohammad Hossein, et al.
Publicado: (2021)

Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway
por: Wang, Lidong, et al.
Publicado: (2021)

Loss of ID3 drives papillary thyroid cancer metastasis by targeting E47-mediated epithelial to mesenchymal transition
por: Xu, Sunwang, et al.
Publicado: (2021)

An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma
por: Takeyama, Hiroshi, et al.
Publicado: (2014)

FKBP51 promotes migration and invasion of papillary thyroid carcinoma through NF-κB-dependent epithelial-to-mesenchymal transition
por: Gao, Ying, et al.
Publicado: (2018)

SIRT6/HIF-1α axis promotes papillary thyroid cancer progression by inducing epithelial–mesenchymal transition
por: Yang, Zhou, et al.
Publicado: (2019)

Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer
por: Wu, Mengwei, et al.
Publicado: (2019)

PRDM16 Inhibits Cell Proliferation and Migration via Epithelial-to-Mesenchymal Transition by Directly Targeting Pyruvate Carboxylase in Papillary Thyroid Cancer
por: Liu, Wan-Lin, et al.
Publicado: (2021)

Bisphenol A at a human exposed level can promote epithelial‐mesenchymal transition in papillary thyroid carcinoma harbouring BRAF (V600E) mutation
por: Li, Liuli, et al.
Publicado: (2021)

DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer
por: Chen, Xianliang, et al.
Publicado: (2015)

E-cadherin on epithelial–mesenchymal transition in thyroid cancer
por: Zhu, Xiaoyu, et al.
Publicado: (2021)

Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma
por: Liang, Wei-Quan, et al.
Publicado: (2019)

TFF3 Contributes to Epithelial-Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma Cells via the MAPK/ERK Signaling Pathway
por: Lin, Xu, et al.
Publicado: (2018)

Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition
por: Ekpe-Adewuyi, Esther, et al.
Publicado: (2016)

Eva‐1 homolog A promotes papillary thyroid cancer progression and epithelial‐mesenchymal transition via the Hippo signalling pathway
por: Lin, Bang‐Yi, et al.
Publicado: (2020)

Correction to: SIRT6/HIF-1α axis promotes papillary thyroid cancer progression by inducing epithelial–mesenchymal transition
por: Yang, Zhou, et al.
Publicado: (2023)

TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
por: Wang, J, et al.
Publicado: (2014)

Impact of Epithelial–Mesenchymal Immunophenotype on Local Aggressiveness in Papillary Thyroid Carcinoma Invading the Airway
por: Mandarano, Martina, et al.
Publicado: (2021)

Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway
por: Luo, Xue, et al.
Publicado: (2022)

MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial–mesenchymal transition
por: Wei, Zhao-li, et al.
Publicado: (2019)

Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer
por: Li, Yuanchun, et al.
Publicado: (2020)

Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
por: Sacristán-Gómez, Pablo, et al.
Publicado: (2023)

miR‐451a inhibits cancer growth, epithelial‐mesenchymal transition and induces apoptosis in papillary thyroid cancer by targeting PSMB8
por: Fan, Xinlong, et al.
Publicado: (2019)

Knockdown of BAG3 induces epithelial–mesenchymal transition in thyroid cancer cells through ZEB1 activation
por: Meng, X, et al.
Publicado: (2014)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Clinical-pathological Characteristics and Prognostic Factors for Papillary Thyroid Microcarcinoma in the Elderly
por: Tang, Jing, et al.
Publicado: (2018)

Editorial: The Role of Epithelial-Mesenchymal Transition-Related Non-Coding RNAs in Cancer
por: Cao, Rui, et al.
Publicado: (2022)

Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression
por: You, Mi-Hyeon, et al.
Publicado: (2021)

MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma
por: Huang, Jia-Yuan, et al.
Publicado: (2015)

Blood prognostic predictors of treatment response for patients with papillary thyroid cancer
por: Liu, Xiangxiang, et al.
Publicado: (2020)

KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT)
por: Jiao, Xuehua, et al.
Publicado: (2019)

Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial‐mesenchymal transition and cancer stem cell‐like properties
por: Lee, Sohee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fib0let1cplqf6cshbkpnsfvu0